Viewing nowEsomeprazole Magnesium Trihydrate Tablets 40 mg
Esomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

MFDS item code 201404652 · Approved 2014.10.10 · Insurance code 648602790
Treatment of reflux disease and Zollinger-Ellison syndrome, ulcers and Helicobacter pylori infection, and NSAID-induced gastrointestinal disorders
This medication is used for the treatment of gastroesophageal reflux disease (GERD) and erosive esophagitis and also helps prevent recurrence in patients with esophagitis. Additionally, it is effective in alleviating symptoms of gastroesophageal reflux disease without esophagitis. It is used as part of combination therapy with antibiotics for the treatment of Helicobacter pylori infection-associated duodenal ulcers and peptic ulcers, also aiding in prevention of recurrence. Furthermore, it is used in treating upper gastrointestinal symptoms and gastric ulcers caused by non-steroidal anti-inflammatory drugs, as well as preventing gastric and duodenal ulcers. This medication is also effective for the treatment of Zollinger-Ellison syndrome and for maintenance therapy to prevent rebleeding from gastric ulcers or duodenal ulcers. It is widely used for the treatment and prevention of various gastrointestinal diseases.
This drug should be swallowed with a liquid such as water and should not be chewed or crushed. 1. Adults 1) Gastroesophageal reflux disease (GERD). - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Long-term maintenance therapy to prevent recurrence in patients with esophagitis: 20 mg once daily - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled by administering 20 mg once daily. · In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 2) Combination therapy with antibiotics for Helicobacter pylori eradication Administer this drug 20 mg in combination with amoxicillin 1 g and clarithromycin 500 mg twice daily for 7 days. 3) Short-term treatment of upper gastrointestinal symptoms (pain, discomfort, burning sensation) associated with nonsteroidal anti-inflammatory drug (nonselective or selective COX-2) use - 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. Clinical trials lasting more than 4 weeks have not been conducted. 4) Patients requiring continuous nonsteroidal anti-inflammatory drug treatment - Treatment of gastric ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. The treatment period is 4∼8 weeks. - Prevention of gastric and duodenal ulcers associated with nonsteroidal anti-inflammatory drug use: 20 mg once daily. 5) Treatment of Zollinger-Ellison syndrome The recommended initial dose is 40 mg twice daily. The dose should be adjusted for each patient, and treatment should continue while clinical symptoms are present. According to clinical data, most patients can be controlled with doses of 80 ∼ 160 mg per day. Doses above 80 mg per day should be divided into 2 doses. 6) Maintenance therapy following intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers Administer 40 mg once daily for 4 weeks following intravenous induction of prevention of rebleeding due to gastric or duodenal ulcers. 3) In adults, 20 mg may be administered once daily as needed. As-needed administration is not recommended for controlling recurrent symptoms in patients at high risk of developing gastric and duodenal ulcers due to nonsteroidal anti-inflammatory drug use. 4. Renal impairment: Dose adjustment is not necessary. Use with caution because there is limited experience in patients with severe renal failure. 5. Hepatic impairment: Dose adjustment is not necessary in patients with mild to moderate hepatic impairment. In patients with severe hepatic impairment, the dose of this drug should not exceed 20 mg. 6. Older adults: Dose adjustment is not necessary.
2. Adolescents aged 12 years and older 1) Gastroesophageal reflux disease (GERD) - Treatment of erosive reflux esophagitis: Administer 40 mg once daily for 4 weeks. Patients whose esophagitis has not healed or whose symptoms persist should take it for an additional 4 weeks. - Symptomatic treatment of gastroesophageal reflux disease without esophagitis: · 20 mg once daily. If symptoms are not controlled after 4 weeks, further evaluation is needed. · Once symptoms have resolved, subsequent recurrent symptoms may be controlled by administering 20 mg once daily. 3. Children under 12 years: There is no experience with administration of this drug to children under 12 years.
This medication should not be administered to certain patients. For example, patients with allergies to this medication or its components, or those with hypersensitivity to certain antibiotics, should not take it. Furthermore, women who are nursing or have a history of certain heart conditions should avoid this medication. When taking this medication, various adverse reactions may occur, necessitating caution. Gastrointestinal symptoms such as headache, abdominal pain, diarrhea, nausea, and vomiting are common, while rare cases of blood abnormalities, skin rash, and muscle pain have also been reported. In severe cases, hypersensitivity reactions such as anaphylaxis or severe skin reactions may occur, thus medical assistance should be sought if symptoms worsen. Long-term use of this medication may lead to electrolyte imbalances such as hypomagnesemia, requiring regular blood tests. Additionally, long-term use may increase the risk of fractures, thus patients with osteoporosis should be cautious. This medication can interact with other drugs, so it is important to consult a doctor, especially when taken with anticoagulants, anticonvulsants, antidepressants, or antiviral agents. Care should be taken as the effects of this medication or others may change when used in combination with certain drugs. Due to limited evidence on the safety of this medication during pregnancy, pregnant women should use it cautiously after consulting a physician. It is advisable for nursing mothers not to take this medication. In cases of overdose, there are no specific antidotes, thus it is crucial to receive appropriate treatment based on symptoms. This medication should be kept out of the reach of children and should not be transferred to other containers.
Leukopenia, thrombocytopenia, agranulocytosis, pancytopenia, fever, angioedema, anaphylactic reaction, shock, peripheral edema, hyponatremia, hypomagnesemia, insomnia, agitation, confusion, depression, aggression, hallucinations, headache, dizziness, perceptual disturbances, drowsiness, dysgeusia, blurred vision, bronchospasm, pancreatitis, abdominal pain, constipation, diarrhea, abdominal bloating, nausea, vomiting, dry mouth, stomatitis, gastrointestinal candidiasis, microscopic colitis, increased liver enzymes, hepatitis, liver failure, encephalopathy, dermatitis, itching, rash, urticaria, alopecia, photosensitivity, erythema multiforme, mucocutaneous syndrome, Stevens-Johnson syndrome, toxic epidermal necrolysis, Liel syndrome, acute generalized exanthematous pustulosis, eosinophilia, drug reactions with systemic symptoms, fractures, arthralgia, myalgia, muscle weakness, interstitial nephritis, gynecomastia, myasthenia, increased sweating, Clostridium difficile diarrhea, abdominal distension, allergic reactions, back pain, chest pain, retrosternal pain, facial edema, facial flushing, fatigue, fever, influenza-like illness, general edema, leg edema, lethargy, pain, stiffness, peripheral edema, flushing, hypertension, tachycardia, thyroid enlargement, irritable bowel syndrome, exacerbation of constipation, dyspepsia, dysphagia, gastrointestinal malformation, epigastric pain, belching, esophageal disorders, frequent bowel movements, gastroenteritis, gastrointestinal bleeding, hiccups, melena, oral disorders, pharyngeal disorders, rectal disorders, gastrointestinal symptoms, increased serum gastrin, tongue disorders, tongue swelling, ulcerative stomatitis, vomiting, earache, tinnitus, anemia, hypopigmented anemia, cervical lymphadenopathy, nosebleeds, leukocytosis, leukopenia, thrombocytopenia, hyperbilirubinemia, liver dysfunction, increased ALT, increased AST, diabetes, hyperuricemia, increased ALP, polydipsia, vitamin B12 deficiency, weight gain, weight loss, exacerbation of arthritis, joint disease, convulsions, fibromyalgia syndrome, hernia, rheumatoid polymyalgia, arthralgia, loss of appetite, apathy, increased appetite, confusion, worsening depression, hypertonicity, agitation, sensory loss, erectile dysfunction, insomnia, migraine, exacerbation of migraine, sleep disorders, tremors, dizziness, visual field defects, perceptual disturbances, drowsiness, dysmenorrhea, menstrual disorders, vaginitis, exacerbation of asthma, cough, dyspnea, laryngeal edema, pharyngitis, rhinitis, sinusitis, acne, anal itching, rash, erythematous rash, papular rash, angioedema, dermatitis, itching, urticaria, increased sweating, otitis media, dysosmia, taste loss, taste distortion, urinary abnormalities, albuminuria, cystitis, dysuria, fungal infections, hematuria, urinary frequency, candidiasis, genital candidiasis, polyuria, conjunctivitis, visual disturbances, duodenitis, esophagitis, esophageal stricture, esophageal ulcer, esophageal varices, gastric ulcer, gastritis, benign polyps or nodules, Barrett's esophagus, mucosal discoloration, hernia, systemic lupus erythematosus, cutaneous lupus erythematosus, hypocalcemia, hypokalemia, rhabdomyolysis
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The storage temperature should be maintained between 1 degree and 30 degrees Celsius at room temperature.
Pink round film-coated tablets
28 tablets (14 tablets/PTP x 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowEsomeprazole Magnesium Trihydrate 43.38mg
Tablet · Prescription medication
CMG Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Trihydrate 44.5mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Esomeprazole Magnesium Dihydrate 43.38mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Esomeprazole Magnesium Dihydrate 21.69mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Esomeprazole Magnesium Trihydrate 22.3mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.